microlax

Medicinal product

(Invented) name

microlax

Active substance (s)

Sorbitolis/Natrio citratas/Natrio laurilsulfoacetatas

Strength

625 mg/90 mg/9 mg/ml

Pharmaceutical form

tiesiosios žarnos tirpalas

Route (s) of administration

vartoti į tiesiąją žarną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

A06AG11, sodium lauryl sulfoacetate, incl. combinations

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2021-11-26

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Sorbitolis	625 mg
Natrio citratas dihidratas	90 mg
Natrio laurilsulfoacetatas	9 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107673	93778	1093778	tūbelė	tūbelė, 5 ml N4		Nereceptinis	LT/L/21/1626/001	Netiekiama	-	-	No	-	-
107674	93779	1093779	tūbelė	5 ml N12		Nereceptinis	LT/L/21/1626/002	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-11-26	Registruotas